Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Mar;115(3):547-55.
doi: 10.1172/JCI24405.

Mitochondrial energy metabolism in heart failure: a question of balance

Janice M Huss  1 , Daniel P Kelly
Affiliations
Review

Mitochondrial energy metabolism in heart failure: a question of balance

Janice M Huss et al. J Clin Invest. 2005 Mar.

Abstract

The mitochondrion serves a critical role as a platform for energy transduction, signaling, and cell death pathways relevant to common diseases of the myocardium such as heart failure. This review focuses on the molecular regulatory events and downstream effector pathways involved in mitochondrial energy metabolic derangements known to occur during the development of heart failure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathways involved in cardiac energy metabolism. FA and glucose oxidation are the main ATP-generating pathways in the adult mammalian heart. Acetyl-CoA derived from FA and glucose oxidation is further oxidized in the TCA cycle to generate NADH and FADH2, which enter the electron transport/oxidative phosphorylation pathway and drive ATP synthesis. Genes encoding enzymes involved at multiple steps of these metabolic pathways (i.e., uptake, esterification, mitochondrial transport,and oxidation) are transcriptionally regulated by PGC-1α with its nuclear receptor partners, including PPARs and ERRs (blue text). Glucose uptake/oxidation and electron transport/oxidative phosphorylation pathways are also regulated by PGC-1α via other transcription factors, such as MEF-2 and NRF-1. Cyt c, cytochrome c.
Figure 2
Figure 2
PGC-1α is an integrator of the transcriptional network regulating mitochondrial biogenesis and function. Numerous signaling pathways, including Ca2+-dependent, NO, MAPK, and β-adrenergic pathways (β3/cAMP), activate the PGC-1α directly by increasing either PGC-1α expression or activity. Additionally, the p38MAPK pathway selectively activates PPARα, which may bring about synergistic activation in the presence of PGC-1α, whereas ERK-MAPK has the opposite effect. These signaling pathways transduce physiological stimuli, such as stress, fasting, and exercise, to the PGC-1α pathway. PGC-1α, in turn, coactivates transcriptional partners, including NRF-1 and -2, ERRα, and PPARα, which regulate mitochondrial biogenesis and FA-oxidation pathways. Dashed lines indicate activation mediated by signal transduction pathways in contrast to the coactivation by PGC-1α, which is denoted by solid lines. The arrows from ERRα to the NRFs and the PPAR complex indicate that ERRα activates these pathways at the level of expression.
Figure 3
Figure 3
Cardiac energy substrate selection is a dynamic balance influenced by developmental, physiological, and pathological cues. In the fetal heart, glucose oxidation is favored, whereas FA oxidation serves as the major ATP-generating pathway in the adult myocardium. Significant shifts in substrate preference occur in response to dietary (insulin) and physiological (exercise) stimuli. Certain pathophysiological contexts, such as hypertrophy and ischemia, drive metabolism toward glucose utilization, whereas in uncontrolled diabetes, the heart utilizes FAs almost exclusively. In some cases, as in early response to pressure overload–induced hypertrophy, these metabolic shifts are thought to be protective. Alterations in activity or expression of nuclear receptors (PPARs and ERRs) and PGC-1α mediate these shifts in energy substrate utilization.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail. Rev. 2002;7:115–130. - PubMed
    1. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr. Probl. Cardiol. 1994;19:59–113. - PubMed
    1. Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of the human heart. II. Studies on fat, ketone and amino acid metabolism. Am. J. Med. 1954;16:504–515. - PubMed
    1. Shipp JC, Opie LH, Challoner D. Fatty acid and glucose metabolism in the perfused heart. Nature. 1961;189:1018–1019.
    1. Wisnecki JA, Gertz EQ, Neese RA, Mayr M. Myocardial metabolism of free fatty acids: studies with 14C labelled substrates in humans. J. Clin. Invest. 1987;79:359–366. - PMC - PubMed

Publication types

MeSH terms

Substances

  NODES
Note 1
twitter 2